SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.355
AS - Asia 5.978
EU - Europa 3.230
SA - Sud America 1.272
Continente sconosciuto - Info sul continente non disponibili 528
AF - Africa 234
OC - Oceania 41
Totale 17.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.899
SG - Singapore 1.587
IT - Italia 1.564
BD - Bangladesh 1.522
BR - Brasile 945
HK - Hong Kong 697
CN - Cina 687
VN - Vietnam 630
NL - Olanda 355
CA - Canada 292
FR - Francia 200
DE - Germania 196
JP - Giappone 180
GB - Regno Unito 170
IN - India 147
FI - Finlandia 123
AR - Argentina 111
RU - Federazione Russa 93
MX - Messico 75
ZA - Sudafrica 74
ES - Italia 71
UA - Ucraina 71
EC - Ecuador 70
ID - Indonesia 67
BE - Belgio 57
IQ - Iraq 56
AE - Emirati Arabi Uniti 55
PL - Polonia 55
TR - Turchia 51
AT - Austria 47
PT - Portogallo 47
PK - Pakistan 46
EG - Egitto 41
CO - Colombia 40
AU - Australia 37
SE - Svezia 33
HU - Ungheria 32
VE - Venezuela 31
TW - Taiwan 30
IE - Irlanda 29
JM - Giamaica 29
MY - Malesia 29
MA - Marocco 28
PH - Filippine 27
UZ - Uzbekistan 26
SA - Arabia Saudita 24
CL - Cile 23
PY - Paraguay 21
TN - Tunisia 21
PE - Perù 16
KE - Kenya 14
NP - Nepal 14
DZ - Algeria 13
KZ - Kazakistan 13
NO - Norvegia 13
CH - Svizzera 12
ET - Etiopia 12
IL - Israele 11
BO - Bolivia 10
CR - Costa Rica 10
JO - Giordania 10
LT - Lituania 10
AZ - Azerbaigian 9
HN - Honduras 9
NI - Nicaragua 9
DO - Repubblica Dominicana 8
OM - Oman 8
CZ - Repubblica Ceca 7
IR - Iran 7
RO - Romania 7
PA - Panama 6
TH - Thailandia 6
AM - Armenia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 5
NG - Nigeria 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
BB - Barbados 4
BY - Bielorussia 4
GT - Guatemala 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
PS - Palestinian Territory 4
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
LY - Libia 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CD - Congo 2
Totale 17.076
Salva come PNG Salva come JPEG
Città #
Ashburn 877
Singapore 821
San Jose 820
Hong Kong 690
New York 535
Los Angeles 293
Dallas 281
Council Bluffs 209
Ho Chi Minh City 207
Beijing 191
Tokyo 169
Hanoi 163
Chicago 135
Milan 125
Buffalo 121
Rome 116
Santa Clara 116
Amsterdam 97
Bologna 91
Toronto 84
São Paulo 81
Helsinki 73
Lauterbourg 70
Orem 69
Naples 68
Montreal 60
Utrecht 53
Atlanta 50
Hefei 48
Warsaw 48
Phoenix 47
Denver 44
San Francisco 44
Turin 42
Abu Dhabi 39
Quito 39
Florence 38
Groningen 38
Lisbon 38
Mexico City 38
Frankfurt am Main 36
Lappeenranta 36
Brooklyn 35
Bari 34
Da Nang 33
Poplar 32
Boston 31
Haiphong 31
Nuremberg 31
Budapest 30
Palermo 30
Paris 29
Baghdad 28
Barcelona 28
Mulhouse 28
Boardman 27
Houston 27
Salt Lake City 27
Vancouver 27
De Lier 26
Dublin 26
Stockholm 26
Seattle 25
Cairo 24
Charlotte 24
Des Moines 24
Belo Horizonte 23
Dhaka 23
London 23
Rio de Janeiro 23
Taichung 23
Miami 22
Tashkent 22
Curitiba 21
Johannesburg 21
Sydney 21
Pasadena 20
Tampa 20
Hải Dương 19
Falkenstein 18
Ferrara 18
Figino 18
Guayaquil 18
Shanghai 18
Brasília 17
Chennai 17
Naaldwijk 17
Hangzhou 16
Jakarta 16
Kuala Lumpur 16
Madrid 16
Guarulhos 15
Munich 15
Washington 15
Caracas 14
Catania 14
Genoa 14
Lima 14
Manchester 14
Venice 14
Totale 8.538
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 1.130
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 457
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 351
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 231
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 193
Desmoteplase 192
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 170
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 164
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 160
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 154
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 144
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 143
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 140
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 134
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 131
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 127
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 127
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 123
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 117
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 113
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 112
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 109
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 109
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 106
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 104
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 104
Un caffè tra due amici al bar. L'esame obiettivo neurologico 104
Treatments in Ischemic Stroke: Current and Future 104
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 103
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 102
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 101
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 101
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 101
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 100
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 100
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 98
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 97
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 96
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 94
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 93
History of stroke 92
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 91
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 90
Medical versus neurosurgical treatment in ICH patients: a single center experience 90
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 90
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 90
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 89
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 87
Consensus paper on the management of acute isolated vertigo in the emergency department 86
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 85
History of cardiac embolism 84
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 83
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 83
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 83
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 82
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 82
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 82
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 82
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 82
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 82
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 81
Sex-related differences in clinical characteristics, treatment and outcomes in patients with atrial fibrillation and acute ischemic stroke treated with non-vitamin-K antagonists 81
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 80
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 79
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 79
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 79
Pure sensory syndromes in thalamic stroke 78
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 78
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 78
Predictors of severe intracerebral hemorrhage expansion 77
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 77
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-Analysis 76
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 76
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 74
The turning point in stroke investigation for neurologists 73
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 73
Anticoagulation After Stroke in Patients With Atrial Fibrillation 73
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 72
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 71
A case of typical headache with an atypical diagnosis 71
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 71
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 70
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 70
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 70
Migraine and Cryptogenic Ischemic Stroke 68
A sudden neurological deficit in a patient with endocarditis 68
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 68
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 68
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 68
Acute stroke symptoms: Do differences exist between sexes? 67
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 67
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 67
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 67
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 67
Seasonal variability in spontaneous cervical artery dissection 66
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 65
The concept of ischemic penumbra in acute stroke and therapeutic opportunities 65
Semeiotica e gestione delle urgenze neurologiche 65
Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis 64
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 62
Totale 11.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.030
Totale 68.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 2 1 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/202614.178 571 675 1.161 1.559 1.337 480 789 616 1.055 1.611 1.988 2.336
2026/20271.295 1.295 0 0 0 0 0 0 0 0 0 0 0
Totale 17.638